The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
Open Access
- 14 October 2023
- journal article
- review article
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (12) , 2015-2030
Abstract
Body composition is related to cardiometabolic disorders and is a major driver of the growing incidence of type 2 diabetes mellitus (T2DM). Altered fat distribution and decreased muscle mass are related to dysglycemia and impose adverse health-related outcomes in people with T2DM. Hence, improving body composition and maintaining muscle mass is crucial in T2DM. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are novel glucose-lowering medications gaining popularity because of their cardiorenal-protective effects and weight-lowering characteristics. However, reports on myopathy secondary to SGLT2 inhibitor treatment raised a safety concern. The importance of maintaining muscle mass in people with T2DM necessitates further investigation to explore the impact of novel medications on body composition. In this review, we discussed current evidence on the impact of SGLT2 inhibitors on body composition in people with T2DM.Keywords
This publication has 84 references indexed in Scilit:
- SGLT-2 Inhibitors: A New Mechanism for Glycemic ControlClinical Diabetes, 2014
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trialThe Lancet, 2013
- Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metforminDiabetes, Obesity and Metabolism, 2013
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminThe Journal of Clinical Endocrinology & Metabolism, 2012
- Sarcopenia and diabetes: pathogenesis and consequencesBritish Journal of Diabetes, 2011
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal TubuleJournal of the American Society of Nephrology, 2011
- Is bioelectrical impedance accurate for use in large epidemiological studies?Nutrition Journal, 2008
- Changes in fat-free mass during significant weight loss: a systematic reviewInternational Journal of Obesity, 2006
- Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in MenDiabetes Care, 1994
- Physiological responses to slimmingProceedings of the Nutrition Society, 1991